Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

AstraZeneca, Glaxo, Renault, 3i, Total: European Equity Preview

April 30 (Bloomberg) -- The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index rose 0.8 percent to 259.12. The Stoxx 50 Index increased 0.6 percent to 2,423.41. The Euro Stoxx 50 Index, a benchmark measure for nations using the euro, gained 0.9 percent to 2,344.02.

3i Group Plc (III LN): The London-based private equity firm is preparing to sell women’s fashion retailer Hobbs Ltd. for as much as 250 million pounds ($407 million), the Sunday Telegraph reported, without saying where it got the information. The shares rose 3.5 percent to 192.2 pence.

AstraZeneca Plc (AZN LN): Departing Chief Executive Officer David Brennan could get as much as 40 million pounds as part of his exit package, the Sunday Times said, without saying where it got the information. The shares rose 0.5 percent to 2,680.5 pence.

Daimler AG (DAI GR): The German maker of Mercedes-Benz cars has prepared measures to complicate continued operation at the company in the case of a hostile takeover, Automobilwoche reported, without saying where it got the information. The shares slid 1.5 percent to 41.99 euros.

Heidelberger Druckmaschinen AG (HDD GR): Chief Executive Officer Bernhard Schreier sees an end to the years of decline for Germany’s printing-press manufacturers, according to an interview with Welt am Sonntag. The shares rose 2.1 percent to 1.31 euros.

GlaxoSmithKline Plc (GSK LN): The pharmaceutical company’s $2.6 billion offer for Human Genome Sciences Inc. “completely undervalues” the company, the Sunday Times said, citing Mark Evans from Taube Hodson Stonex Partners LLP, a fund manager that owns 5.6 percent of the U.S. drugs maker. The shares rose 0.3 percent to 1,423.5 pence.

Renault SA (RNO FP): The French carmaker’s joint venture with Dongfeng Motor Group of China could begin producing cars for the world’s largest auto market by the end of 2015, Renault Chief Executive Officer Carlos Ghosn said. The shares gained 3.1 percent to 35.68 euros.

Standard Chartered Plc (STAN LN): PIRC, a U.K. corporate governance activist organization, is urging Standard Chartered Plc shareholders to vote against the bank’s remuneration report at its annual general meeting on May 9, the Sunday Telegraph said, citing a copy of PIRC’s recommendations. The shares rose 0.4 percent to 1,523 pence.

Telecom Italia SpA (TIT IM): The Italian telecom operator’s largest shareholders will discuss a capital increase for Telco SpA, the company’s controlling vehicle, at a May 3 meeting, Il Sole 24 Ore reported, without saying where it got the information. The shares gained 1.8 percent to 87 euro cents.

Total SA (FP FP): Europe’s third-largest oil company said it expects to halt a monthlong natural-gas leak in the North Sea by plugging the well with mud. The shares declined less than 0.1 percent to 36.50 euros.

Wendel (MF FP): France’s largest publicly traded investment firm has begun gauging potential interest in Materis SA’s aluminates and admixtures units, valued at a potential 1 billion euros ($1.3 billion) combined, four people with knowledge of the plan said. The shares rose 1.7 percent to 57.86 euros.

To contact the reporters on this story: Joseph Ciolli in New York at jciolli@bloomberg.net; Anne-Sylvaine Chassany in London at achassany@bloomberg.net

To contact the editor responsible for this story: Dick Schumacher at dschumacher@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.